| Texto completo | |
| Autor(es): |
Fischer-Carvalho, Agatha
;
Taveira-Barbosa, Tereza Cristina
;
Verjovski-Almeida, Sergio
;
Haeberlein, Simone
;
Amaral, Murilo Sena
Número total de Autores: 5
|
| Tipo de documento: | Artigo Científico |
| Fonte: | MICROORGANISMS; v. 13, n. 2, p. 17-pg., 2025-02-01. |
| Resumo | |
Schistosomiasis is a neglected tropical disease that affects over 240 million people worldwide. Currently, praziquantel is the only drug recommended by the World Health Organization for treatment. However, cases of drug resistance have been reported, which indicates an urgent need for new therapeutics. In this context, natural compounds represent valuable sources of pharmacological substances. Plant-derived natural products have been greatly explored for their potential antischistosomal activity, while animal-derived compounds have received little attention. Recent advances in the biotechnology field allow the wide exploration of animal-derived compounds in drug discovery, which may represent a cost-effective option to find bioactive molecules also against Schistosoma mansoni and other parasites. This review highlights the research into animal-derived products and compounds that have already been tested against schistosomes. Phenotypic effects on schistosomes have been observed upon incubation with some of these substances, which may, therefore, represent possible candidates to be used in the development of new drugs. Overall, these studies advance the discovery of antischistosomal compounds by exploring a yet understudied natural resource. The present review also discusses the challenges of testing animal-derived products and provides examples of the experimental in vitro testing of different selected animal natural products against S. mansoni. (AU) | |
| Processo FAPESP: | 18/23693-5 - Mecanismos de ação de RNAs longos não-codificadores envolvidos nos programas de ativação gênica em eucariotos |
| Beneficiário: | Sergio Verjovski Almeida |
| Modalidade de apoio: | Auxílio à Pesquisa - Temático |